Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current perspectives on intracavernosal pharmacotherapy for erectile dysfunction.

H Porst1

  • 1Neuer Jungfernstieg 6a, 20354 Hamburg, Germany. PORST20354@aol.com

International Journal of Impotence Research
|October 18, 2000
PubMed
Summary

Intracavernosal injection therapy offers a viable treatment for erectile dysfunction (ED) when oral drugs fail or are contraindicated. This method provides rapid and reliable results for ED patients seeking effective pharmacotherapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Value of prolonged scrotal drainage after penile prosthesis implantation: a multicenter prospective nonrandomized pilot study.

International journal of impotence research·2023
Same author

Physicians' attitudes towards androgen replacement therapy for male and female sexual dysfunction.

International journal of impotence research·2016
Same author

Results from an online survey investigating ED patients' insights and treatment expectations.

International journal of impotence research·2015
Same author

Continuation and effectiveness of tadalafil once daily during a 6-month observational study in erectile dysfunction: the EDATE study.

International journal of clinical practice·2014
Same author

Genetic association study of the GNB3 C825T, the ACE I/D and the eNOS G894T polymorphisms and the risk to develop erectile dysfunction in a German ED population.

Andrologia·2010
Same author

[Chronic PDE-5 inhibition in patients with erectile dysfunction: new treatment approach using once daily Tadalafil].

Der Urologe. Ausg. A·2009

Area of Science:

  • Urology
  • Pharmacology
  • Andrology

Background:

  • Erectile dysfunction (ED) affects a significant number of males.
  • Oral pharmacotherapies are not effective for all patients with ED.
  • Some patients prefer alternative ED treatments due to efficacy and onset time.

Purpose of the Study:

  • To provide a historical and current overview of intracavernosal therapy for ED.
  • To review established and emerging injectable therapeutic agents for ED.
  • To analyze the efficacy, mechanism of action, and side effect profiles of injectable ED pharmacotherapy.

Main Methods:

  • Literature review of intracavernosal therapy for ED.
  • Analysis of approved and experimental injectable pharmacotherapy.
  • Evaluation of efficacy, onset time, rigidity, and side effect profiles.

Related Experiment Videos

Main Results:

  • Thirty percent of males with ED do not respond to oral drugs.
  • Fifteen percent have contraindications to current oral ED therapies.
  • Injection therapy offers predictable, rapid onset and reliable rigidity.

Conclusions:

  • Intracavernosal injection therapy is a crucial treatment option for ED.
  • It addresses limitations of oral therapies for a significant patient subset.
  • Further research into approved and experimental injectable pharmacotherapy is warranted.